论文部分内容阅读
目的分析胺碘酮对心力衰竭合并心律失常患者的治疗效果。方法 2015年1-10月,于滨海新区汉沽中医医院纳入心力衰竭合并心律失常患者75例,进行随机分组。其中接受常规治疗者37例,设为对照组;在该基础上,给予其余38例患者胺碘酮治疗,设为观察组,对比两组疗效。结果两组中观察组的治疗有效率为94.74%,对照组治疗有效率为83.78%,两组比较差异有统计学意义(P<0.05)。在静息心率、血压及心功能改善观察组明显优于对照组,两组比较差异均有统计学意义(P<0.05)。结论心力衰竭合并心律失常患者采用胺碘酮治疗,效果确切,值得临床推广应用。
Objective To analyze the effect of amiodarone on patients with heart failure and arrhythmia. Methods From January to October 2015, 75 patients with heart failure and arrhythmia were enrolled in Hangu Hospital of Traditional Chinese Medicine, Binhai New District, for randomization. Among them, 37 cases received routine treatment, which were set as control group. On the basis, the other 38 cases were given amiodarone treatment, which was treated as observation group and compared the curative effect of the two groups. Results The effective rate of treatment was 94.74% in the observation group and 83.78% in the control group. The difference between the two groups was statistically significant (P <0.05). Resting heart rate, blood pressure and heart function improvement in the observation group was significantly better than the control group, the difference between the two groups were statistically significant (P <0.05). Conclusions Patients with heart failure and arrhythmia treated with amiodarone have definite effect and worthy of clinical application.